Status:
COMPLETED
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms...
Eligibility Criteria
Inclusion
- Aged over 18
- Confirmed diagnosis of mild to moderate asthma by doctor
- Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment
Exclusion
- Women who are pregnant, breast-feeding, or planning pregnancy
- Patients with a history of chronic obstructive pulmonary disease
- Patients using any beta blocker therapy
- Patients receiving steroid tablets or steroid injections
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT00319306
Start Date
September 1 2005
End Date
December 1 2006
Last Update
March 17 2009
Active Locations (59)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Fowey, Cornwall, United Kingdom
2
Research Site
Hove, East Sussex, United Kingdom
3
Research Site
Ilford, Essex, United Kingdom
4
Research Site
Glenrothes, Fife, United Kingdom